Mireille Hobeika, PharmDExpert Contributor
- Patients' adherence to long-term treatment
- 2017 - President Award from AbbVie for Outstanding Contribution to the Dermatology Division
- 2016 - Amaze Award from AbbVie for Successful Completion of Clinical Trials in Middle East Region
- 2013 - Excellence Award from AbbVie for Best Educational Seminar of the Year
- Doctor of Pharmacy, University of St. Joseph, West Hartford, Connecticut
Mireille Hobeika obtained a doctorate in pharmacy in 2005 and has worked for several years in various international pharmaceutical companies. As a medical manager, her main interest was to create programs to educate patients with chronic conditions about their diseases and available therapies.
Hobeika believes in empowering patients. She believes that before being initiated on a new drug, the patient must be well informed on what to expect from it — in the short and long term — and must participate in the decision-making. Patients should also be made aware about alternative therapies and be engaged in choosing the therapy that they believe is right for them. This will increase the patients trust and compliance which will consequently improve treatment outcomes.
“With all the medical innovations and rapid progress, new treatment options have become numerous and complex. Compared to just a decade ago, patients have so many more options to choose from. And the choices can be difficult. So, patients must be informed and empowered. The traditional doctor-patient relationship does not lead to the best results. Doctors and patients must be partners to decide together what the best treatment for the individual patient is.”
– Mireille Hobeika, PharmD, Expert Contributor
Through her involvement with Drugwatch, Hobeika would like to help raise awareness on various drugs and their implications on patients’ health.
Over the last few years, Hobeika has authored three books about the importance of empowering patients and building a partnership between physicians and patients. A true partnership, rather than the traditional patient-doctor relationship, improves the patient’s adherence to medication — and thus outcomes.
In 2017, Hobeika led an initiative which culminated in the official endorsement of a national program to standardize the development of a doctor-patient partnership and improving the patient’s adherence to medications.